Bioventus Inventory

Bioventus (BVS) currently reports a inventory of $80M as of June 2026. That compares with $96M in the prior-year period — down 17.3% year over year. Use the charts on this page to explore Bioventus's inventory history and peer comparisons.

Bioventus's inventory decreased from $96M to $80M — a 17.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bioventus reported $80M in inventory as of June 2026. That compares with $96M in the prior-year period — down 17.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $80M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bioventus, and consider following BVS for alerts when major investors trade the stock.

Bioventus is classified in the Healthcare sector. On inventory, it currently shows $80M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BVS with unrelated industries.